Open AccessClinical Outcomes of Early Immunotherapy Cessation in Metastatic Melanoma
Author(s) -
Dibash Kumar Das
Publication year - 2021
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000754700.05681.e4
Subject(s) - pembrolizumab , medicine , nivolumab , melanoma , adverse effect , oncology , immunotherapy , cancer , ipilimumab , clinical trial , cancer research